A randomized controlled fixed-dose trial of olanzapine for psychosis in Parkinson disease

Michelle J. Nichols, Washington University School of Medicine in St. Louis
Johanna M. Hartlein, Washington University School of Medicine in St. Louis
Meredith G. Albin, Washington University School of Medicine in St. Louis
Bradley A. Racette, Washington University School of Medicine in St. Louis
Kevin J. Black, Washington University School of Medicine in St. Louis

This work is a preprint and has not been published.

The study was presented at the American Neuropsychiatric Association Annual Meeting, Tucson, AZ, 18 February 2007. The abstract for the presentation was published in the The Journal of Neuropsychiatry and Clinical Neurosciences, 2007;19:213-235.

Abstract

This paper has been withdrawn.